Prognostic Factors and Therapy Assessment of IgA Nephropathy: Report from a Single Unit in Iran

REFERENCES

• D’Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987;64:709–727.
   PubMedGoogle Scholar
• Schena FP. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med. 1990;89:209–215.
   PubMed Web of Science ®Google Scholar
• Coppo R, Amore A, Hogg R, Emancipator S. Idiopathic nephropathy with IgA deposits. Pediatr Nephrol. 2000;15:139–150.
   PubMedGoogle Scholar
• Clarksson AR, Woodroffe AJ, Aarons I. IgA nephropathy in patients followed-up for at least ten years. Semin Nephrol. 1987;7:377–378.
   PubMedGoogle Scholar
• D’Amico G, Colasanti G, di Belgioioso GB, et al. Long term follow up of IgA mesangial nephropathy: Clinico-histological study in 374 patients. Semin Nephrol. 1987;7:355–358.
   PubMed Web of Science ®Google Scholar
• Johnston PA, Brown JS, Braumholtz DA, Davison AM. Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. Q J Med. 1992;84:619–627.
   PubMedGoogle Scholar
• Ygame M, Suzuki D, Jiade K, . Value of pathological grading in prediction of renal survival in IgA nephropathy. Nephrology. 1996;2:107–117.
   Google Scholar
• D’Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004;24:179–196.
   PubMed Web of Science ®Google Scholar
• Beukhof JR, Kardaun O, Schaafsma W, . Toward individual prognosis of IgA nephropathy. Kidney Int. 1986;29:549–556.
   PubMedGoogle Scholar
• Manno C, Giovanni F, Strippoli M, Torres D, Rossini M, Schena FP. A novel simpler histological classification for renal survival in IgA nephropathy: A retrospective study. Am J Kid Dis. 2007;49:763–775.
   PubMed Web of Science ®Google Scholar
• Julian BA, Waldo FB, Rifai A, Mestecky J. IgA nephropathy, the most common glomerulonephritis world-wide: A neglected disease in the United States? Am J Med. 1988;84:129–132.
   PubMed Web of Science ®Google Scholar
• Nicholls KM, Fairly KF, Dowling JP, Kincaid-Smith P. The clinical course of mesangial IgA associated nephropathy in adults. Q J Med. 1984;53:22–50.
   Google Scholar
• D’Amico G, Minetti L, Ponticelli G, . Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med. 1986;59:363–378.
   PubMedGoogle Scholar
• Woo KT, Edmondson RPS, Wu AYT, . The natural history of IgA nephritis in Singapore. Clin Nephrol. 1986;25:15–21.
   PubMed Web of Science ®Google Scholar
• Kusumoto Y, Takebayashi S, Taguchi T, Harada T, Naito S. Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and adult Japanese. Clin Nephrol. 1987;28:118–124.
   PubMedGoogle Scholar
• Velo M, Lozano L, Egido J, Gutierrez-Millet V, Hernando L. Natural history of IgA nephropathy in patients followed up for more than ten years in Spain. Semin Nephrol. 1987;7:346–350.
   PubMedGoogle Scholar
• Bogenschutz O, Bohle A, Batz C, . IgA nephritis: On the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol. 1990;10:137–147.
   PubMed Web of Science ®Google Scholar
• Rekola S, Bergstrand A, Buch H. IgA nephropathy. Development of hypertension in IgA nephropathy as a marker of poor prognosis. Am J Nephrol. 1990;10:290–295.
   PubMedGoogle Scholar
• Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses. Am J Kidney Dis. 1991;18:12–19.
   PubMed Web of Science ®Google Scholar
• Ibels LS, Gyory AZ. IgA nephropathy: Analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine. 1994;73:79–109.
   PubMed Web of Science ®Google Scholar
• Li T, Ho L, Szeto C, Yu LyMee, Lai M-M. Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives. Nephrol Dial Transplant. 2002;17:64–69.
   PubMed Web of Science ®Google Scholar
• D’Amico G. Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: Survey of the recent literature. Am J Kidney Dis. 1992;20:315.
   PubMed Web of Science ®Google Scholar
• Szeto CC, Lai F, To KF, . The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med. 2001;110:434.
   PubMed Web of Science ®Google Scholar
• D’Amico G. Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors. Am J Kidney Dis. 2000;36:227.
   PubMed Web of Science ®Google Scholar
• Rekola S, Bergstrand A, Bucht H. Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance. Kidney Int. 1991;40:1050.
   PubMedGoogle Scholar
• Nozawa R, Suzuki J, Takahashi A, . Clinicopathological features and the prognosis of IgA nephropathy in Japanese children on long-term observation. Clin Nephrol. 2005;64:171.
   PubMedGoogle Scholar
• Lau KK, Gaber LW, Delos Santos NM, Fisher KA, Grimes SJ, Wyatt RJ. Pediatric IgA nephropathy: Clinical features at presentation and outcome for African-Americans and Caucasians. Clin Nephrol. 2004;62:167.
   PubMedGoogle Scholar
• Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting progression in IgA nephropathy. Am J Kidney Dis. 2001;38:728.
   PubMed Web of Science ®Google Scholar
• Hall CL, Bradley R, Kerr A, Attoti R, Peat D. Clinical value of renal biopsy in patients with asymptomatic microscopic hematuria with and without low-grade proteinuria. Clin Nephrol. 2004;62:267.
   PubMedGoogle Scholar
• Ikee R, Kobayashi S, Saigusa T, . Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy. Hypertens Res. 2006;29:15.
   PubMedGoogle Scholar
• Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant. 2002;17:1197.
   PubMed Web of Science ®Google Scholar
• Reich HN, Troyanov S, Scholey JW, Cattran DC. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007;18:3177.
   PubMed Web of Science ®Google Scholar
• Haas M. Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29:829.
   PubMed Web of Science ®Google Scholar
• Lee HS, Lee MS, Lee SM, . Histological grading of IgA nephropathy predicting renal outcome: Revisiting H. S. Lee’s glomerular grading system. Nephrol Dial Transplant. 2005;20:342.
   PubMed Web of Science ®Google Scholar
• Geddes CC, Rauta V, Gronhagen-Riska C, . A tricontinental view of IgA nephropathy. Nephrol Dial Transplant. 2003;18:1541.
   PubMedGoogle Scholar
• Radford MG, Donadio JV, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol. 1997;8:199–207.
   PubMed Web of Science ®Google Scholar
• Schena FP. Immunoglobulin A nephropathy with mild renal lesions: A call in the forest for physicians and nephrologists. Am J Med. 2001;110:499–500.
   PubMed Web of Science ®Google Scholar
• Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: A long-term follow up of 204 cases in China. Nephrology. 2008;13:242–246.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Tateno S. Moderately proteinuric IgA nephropathy: Prognostic prediction of individual clinical courses and steroid therapy in progressive cases. Nephron. 1989;53:250.
   PubMedGoogle Scholar
• Kobayashi Y, Hiki Y, Kokubo T, Horii A, Tateno S. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. Nephron. 1996;72:237.
   PubMed Web of Science ®Google Scholar
• Pozzi C, Bolasco PG, Fogazzi GB, . Corticosteroids in IgA nephropathy: A randomised controlled trial. Lancet. 1999;353:883.
   PubMed Web of Science ®Google Scholar
• Pozzi C, Andrulli S, Del Vecchio L, Melis P. Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15:157.
   PubMed Web of Science ®Google Scholar
• Tamura S, Ueki K, Ideura H, . Corticosteroid therapy in patients with IgA nephropathy and impaired renal function. Clin Nephrol. 2001;55:192.
   PubMedGoogle Scholar
• Moriyama T, Honda K, Nitta K, Yumura W, Nihei H. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function. Clin Exp Nephrol. 2004;8:237.
   PubMedGoogle Scholar
• Lv J, Zhang H, Chen Y, . Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: A randomized controlled trial. Am J Kidney Dis. 2009;53:26.
   PubMed Web of Science ®Google Scholar
• Manno C, Torres DD, Rossini M, Pesce F, Schena FP. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Nephrol Dial Transplant. 2009;24:3694.
   PubMed Web of Science ®Google Scholar